Financial Performance
Hanmi Pharm: Economic Value Created and Distributed (non-consolidated)
Category | Unit | 2023 | 2024 | 2025 |
|---|---|---|---|---|
Economic Value Generated | ||||
Sales Revenue | KRW 100M | 10,969 | 11,141 | 11,466 |
(1) Domestic Sales | KRW 100M | 8,943 | 9,164 | 9,364 |
(2) Exports (excluding royalties) | KRW 100M | 1,771 | 1,902 | 1,937 |
(3) Royalties | KRW 100M | 255 | 76 | 165 |
Economic Value Distributed | ||||
Research and Development Expenses | KRW 100M | 1,649 | 1,676 | 1,901 |
Employee training expenses | KRW 100M | 23 | 33 | 26 |
Social contribution expenses + Donations | KRW 100M | 94.4 | 71.5 | 54.8 |
Purchases from suppliers | KRW 100M | 2,255 | 2,166 | 2,449 |
Dividends | KRW 100M | 62 | 159 | 254 |
Earnings per share (EPS) | KRW | 8,602 | 10,298 | 10,093 |
ROE | % | 17 | 17.6 | 14.9 |
Corporate tax expense (income) | KRW 100M | 182 | 186 | 166 |
Summary of Performance for the Past 3 Fiscal Years
Category | Unit | 2023 | 2024 | 2025 |
|---|---|---|---|---|
Sales Revenue | KRW 100M | 10,969 | 11,141 | 11,466 |
(1) Product sales | KRW 100M | 8,863 | 9,292 | 9,689 |
(2) Merchandise sales | KRW 100M | 1,665 | 1,641 | 1,331 |
(3) Toll manufacturing sales | KRW 100M | 114 | 108 | 167 |
(4) Technology export revenue | KRW 100M | 255 | 76 | 165 |
(5) Other revenue | KRW 100M | 72 | 24 | 114 |
Cost of sales | KRW 100M | 5,668 | 5,818 | 5,331 |
(1) Cost of product sales | KRW 100M | 4,043 | 4,243 | 4,091 |
(2) Cost of merchandise sales | KRW 100M | 1,559 | 1,536 | 1,187 |
(3) Cost of toll manufacturing sales | KRW 100M | 66 | 39 | 53 |
Cost of sales ratio | % | 51.7 | 52.2 | 46.5 |
Selling and administrative expenses | KRW 100M | 2,516 | 2,530 | 2,694 |
Selling and administrative expense ratio | % | 22.9 | 22.7 | 23.5 |
Operating profit | KRW 100M | 1,490 | 1,327 | 1,778 |
Operating profit margin | % | 13.6 | 11.9 | 15.5 |
Profit before tax | KRW 100M | 1,273 | 1,492 | 1,445 |
Profit before tax margin | % | 11.6 | 13.4 | 12.6 |
Net profit | KRW 100M | 1,092 | 1,306 | 1,280 |
Net profit margin | % | 10 | 11.7 | 11.2 |
Beijing Hanmi: Economic Value Created and Distributed (non-consolidated)
Category | Unit | 2023 | 2024 | 2025 |
|---|---|---|---|---|
Economic Value Generated | ||||
Sales Revenue | CNY 1,000 | 2,158,799 | 2,038,267 | 2,040,624 |
(1) Domestic Sales | CNY 1,000 | 2,157,099 | 2,038,040 | 2,040,386 |
(2) Exports (excluding royalties) | CNY 1,000 | 1,700 | 227 | 238 |
(3) Royalties | CNY 1,000 | 0 | 0 | 0 |
Economic Value Distributed | ||||
Research and Development Expenses | CNY 1,000 | 175,369 | 174,757 | 153,243 |
Employee training expenses | CNY 1,000 | 1,146 | 905 | 944 |
Social contribution expenses + Donations | CNY 1,000 | 14,388 | 36,907 | 32,498 |
Purchases from suppliers | CNY 1,000 | 485,675 | 428,801 | 452,857 |
Dividends | CNY 1,000 | 224,000 | 424,000 | 60,000 |
Earnings per share (EPS) | CNY | 0 | 0 | 0 |
ROE | % | 18.1 | 16 | 13.5 |
Corporate tax expense (income) | CNY 1,000 | 60,652 | 56,129 | 51,132 |
Hanmi Fine Chemical: Economic Value Created and Distributed (non-consolidated)
Category | Unit | 2023 | 2024 | 2025 |
|---|---|---|---|---|
Economic Value Generated | ||||
Sales Revenue | KRW 100M | 1,110 | 1,089 | 913 |
(1) Domestic Sales | KRW 100M | 369 | 352 | 569 |
(2) Exports (excluding royalties) | KRW 100M | 720 | 726 | 329 |
(3) Royalties | KRW 100M | 21 | 1 | 0.2 |
(3) Fees | KRW 100M | 0 | 10 | 15 |
Economic Value Distributed | ||||
Research and Development Expenses | KRW 100M | 78 | 77 | 72 |
Employee training expenses | KRW 100M | 0.68 | 0.75 | 0.5 |
Social contribution expenses + Donations | KRW 100M | 1 | 1 | 0 |
Purchases from suppliers | KRW 100M | 621 | 515 | 315 |
Dividends | KRW 100M | 0 | 0 | 0 |
Earnings per share (EPS) | KRW | -4,336 | -1,072 | 171 |
ROE | % | -6.9 | -1.7 | 0.3 |
Corporate tax expense (income) | KRW 100M | -1 | 1 | 1 |